KI
IMCR icon

Kapitalo Investimentos’s Immunocore IMCR Stock Holding History

Kapitalo Investimentos’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,234
Closed -$160K – 586
2023
Q1 		$160K Buy
3,234
+1,234
+62% +$69.4K 0.05% 199
2022
Q4 		$114K Buy
+2,000
New +$113K 0.09% 48

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kapitalo Investimentos's IMCR Position: Q2 2023 in Review

Kapitalo Investimentos sold out of Immunocore (IMCR) in Q2 2023, closing a stake of 3,234 shares — an estimated $160K sold.

Kapitalo Investimentos first reported a position in IMCR in Q4 2022 and held it in 2 quarters. The position peaked at $160K in Q1 2023. 120 funds tracked by Wall St. Rank hold IMCR as of Q2 2023.

  • Kapitalo Investimentos reported no remaining Immunocore position as of Q2 2023 after selling out during the quarter.
  • Kapitalo Investimentos sold 3,234 Immunocore shares in Q2 2023, an estimated $160K.
  • Kapitalo Investimentos first reported a position in Immunocore in Q4 2022 and held it in 2 quarters.
  • Kapitalo Investimentos's Immunocore position peaked at $160K in Q1 2023.
  • 120 funds tracked by Wall St. Rank held Immunocore as of Q2 2023.

Based on Kapitalo Investimentos's 13F filing for Q2 2023, filed 29 Mar 2024.